| Secondary |
| Cardiac Failure |
17.6% |
| Hypertension |
14.7% |
| Atrial Fibrillation |
8.8% |
| Cough |
5.9% |
| Oedema Peripheral |
5.9% |
| Benign Prostatic Hyperplasia |
4.4% |
| Cardiovascular Disorder |
4.4% |
| Hypokalaemia |
4.4% |
| Sleep Disorder |
4.4% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Chronic Sinusitis |
2.9% |
| Diabetes Mellitus |
2.9% |
| Diarrhoea |
2.9% |
| Hiv Infection |
2.9% |
| Pain |
2.9% |
| Pneumonia |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Psoriasis |
2.9% |
| Colonoscopy |
1.5% |
| Dyslipidaemia |
1.5% |
|
| Sudden Death |
33.3% |
| Blood Creatinine Increased |
16.7% |
| Renal Failure Chronic |
16.7% |
| Toxic Epidermal Necrolysis |
16.7% |
| Urinary Tract Infection |
16.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.5% |
| Atrial Fibrillation |
10.4% |
| Hypertension |
10.0% |
| Cardiac Failure |
8.1% |
| Drug Use For Unknown Indication |
7.3% |
| Multiple Myeloma |
3.5% |
| Glaucoma |
3.1% |
| Diabetes Mellitus |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Pulmonary Arterial Hypertension |
2.5% |
| Arrhythmia |
2.3% |
| Post Herpetic Neuralgia |
2.3% |
| Prophylaxis |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
| Atrial Flutter |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Cardiac Failure Chronic |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Cardiomyopathy |
1.7% |
| Depression |
1.7% |
|
| Death |
9.1% |
| Vomiting |
9.1% |
| Pneumonia |
7.8% |
| Nausea |
6.5% |
| Thrombocytopenia |
6.5% |
| Pulmonary Embolism |
5.2% |
| Somnolence |
5.2% |
| Ventricular Extrasystoles |
5.2% |
| Cardiac Failure |
3.9% |
| Cerebrovascular Accident |
3.9% |
| Circulatory Collapse |
3.9% |
| General Physical Health Deterioration |
3.9% |
| Oedema Peripheral |
3.9% |
| Pulmonary Oedema |
3.9% |
| Rectal Polyp |
3.9% |
| Renal Failure |
3.9% |
| Speech Disorder |
3.9% |
| Tachyarrhythmia |
3.9% |
| Visual Impairment |
3.9% |
| Brain Natriuretic Peptide Increased |
2.6% |
|
| Interacting |
| Atrial Fibrillation |
66.7% |
| Essential Hypertension |
33.3% |
|
|
